# Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

> **NCT05730777** · PHASE4 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Cancer Therapy-related Cardiovascular Toxicity

## Interventions

- **DRUG:** Bifidobacterium Bifidum Oral Capsule
- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel
- **DRUG:** Atlizumab

## Key facts

- **NCT ID:** NCT05730777
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-15
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05730777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05730777, "Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05730777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*